Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: IDEXX Laboratories Inc., 3 years.
IDEXX Laboratories Inc.
Director
Revvity Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 2026 | IDEXX Laboratories Inc. | Option exercise | +257 | — | — |
| May 7, 2026 | Revvity Inc. | Grant or award | +1,015 | — | — |
| May 7, 2026 | Revvity Inc. | Grant or award | +1,265 | — | — |
| Feb 17, 2026 | IDEXX Laboratories Inc. | Option exercise | +945 | $333.90 | $315,536 |
| Feb 17, 2026 | IDEXX Laboratories Inc. | Open-market sale | −945 | $628.65 | $594,074 |
| Feb 17, 2026 | IDEXX Laboratories Inc. | Open-market sale | −519 | $628.56 | $326,223 |
| May 9, 2025 | IDEXX Laboratories Inc. | Option exercise | +1,279 | $283.59 | $362,712 |
| May 9, 2025 | IDEXX Laboratories Inc. | Open-market sale | −1,279 | $491.34 | $628,424 |
| May 6, 2025 | IDEXX Laboratories Inc. | Option exercise | +262 | — | — |
| Apr 30, 2025 | Revvity Inc. | Grant or award | +1,074 | — | — |
| Apr 30, 2025 | Revvity Inc. | Grant or award | +1,338 | — | — |
| Nov 27, 2024 | IDEXX Laboratories Inc. | Gift | −224 | — | — |
| Nov 27, 2024 | IDEXX Laboratories Inc. | Open-market sale | −344 | $420.44 | $144,631 |
| May 6, 2024 | IDEXX Laboratories Inc. | Option exercise | +257 | — | — |
| May 1, 2024 | Revvity Inc. | Grant or award | +977 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.